Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
April-2021 Volume 45 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2021 Volume 45 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and 131I resistance of thyroid carcinoma cells through PI3K/Akt activation

  • Authors:
    • Wanzhi Chen
    • Jichun Yu
    • Rong Xie
    • Tao Zhou
    • Chengfeng Xiong
    • Shuyong Zhang
    • Meijun Zhong
  • View Affiliations / Copyright

    Affiliations: Department of Thyroid Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 3
    |
    Published online on: January 27, 2021
       https://doi.org/10.3892/or.2021.7954
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Radioactive iodine (RAI, 131I) therapy is the main treatment for thyroid carcinoma (TC). Long noncoding RNA (lncRNA)/microRNA (miR) competing endogenous RNA (ceRNA) networks have aroused great interest for their roles in gene expression. The present study aimed to investigate the effect of lncRNA SNHG7 on the growth and 131I resistance of TC. Differentially expressed lncRNAs in TC and paracancerous tissues were analyzed. The binding of miR‑9‑5p with small nucleolar RNA host gene 7 (SNHG7) and dipeptidyl‑peptidase 4 (DPP4) was identified. Gain‑ and loss‑of‑function analyses of SNHG7 and miR‑9‑5p were performed to determine their effects on the growth and 131I resistance of TC cells. The activity of the PI3K/Akt pathway was evaluated. Consequently, upregulated SNHG7 was revealed in TC tissues and correlated with 131I resistance. Silencing of SNHG7 or overexpressing miR‑9‑5p inhibited the growth and 131I resistance of TC cells. SNHG7 acted as a ceRNA of miR‑9‑5p to enhance DPP4 expression. Overexpressed SNHG7 increased DPP4 expression and activated the PI3K/Akt signaling pathway by sponging miR‑9‑5p. The in vitro results were reproduced in vivo. In summary, the present study provided evidence that the SNHG7/miR‑9‑5p/DPP4 ceRNA network could promote the growth and 131I resistance of TC cells via PI3K/Akt activation. The present study may offer novel options for TC treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Ding C, Yu H, Shi C, Shi T, Qin H and Cui Y: MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in thyroid cancer. Biomed Pharmacother. 110:528–536. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Li H, Zhao L, Zhang Z, Zhang H, Ding C and Su Z: Roles of microRNA let-7b in thyroid cancer by regulating HMGA2. Tumour Biol. 39:10104283177192742017. View Article : Google Scholar : PubMed/NCBI

3 

Huang Y, Yu S, Cao S, Yin Y, Hong S, Guan H, Li Y and Xiao H: MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit b alpha expression. Thyroid. 28:1162–1173. 2018. View Article : Google Scholar : PubMed/NCBI

4 

Gezer E, Selek A, Tarkun I, Canturk Z and Çetinarslan B: Papillary thyroid cancer presenting as a primary renal tumor with multiple pulmonary and bone metastases: A case report. J Med Case Rep. 13:952019. View Article : Google Scholar : PubMed/NCBI

5 

Liu C, Feng Z, Chen T, Lv J, Liu P, Jia L, Zhu J, Chen F, Yang C and Deng Z: Downregulation of NEAT1 reverses the radioactive iodine resistance of thyroid cancer cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle. 18:167–203. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Xiang C, Zhang ML, Zhao QZ, Xie QP, Yan HC, Yu X, Wang P and Wang Y: lncRNA-SLC6A9-5:2: A potent sensitizer in 131I-resistant thyroid cancer with PARP-1 induction. Oncotarget. 8:22954–22967. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Wan ZY, Song F, Sun Z, Chen YF, Zhang WL, Samartzis D, Ma CJ, Che L, Liu X, Ali MA, et al: Aberrantly expressed long noncoding RNAs in human intervertebral disc degeneration: A microarray related study. Arthritis Res Ther. 16:4652014. View Article : Google Scholar : PubMed/NCBI

8 

Chen Y, Shen Z, Zhi Y, Zhou H, Zhang K, Wang T, Feng B, Chen Y, Song H, Wang R and Chu X: Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression. Arch Biochem Biophys. 645:117–125. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Gao YT and Zhou YC: Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381. Eur Rev Med Pharmacol Sci. 23:6588–6595. 2019.PubMed/NCBI

10 

Yao X, Liu C, Liu C, Xi W, Sun S and Gao Z: lncRNA SNHG7 sponges miR-425 to promote proliferation, migration, and invasion of hepatic carcinoma cells via Wnt/β-catenin/EMT signalling pathway. Cell Biochem Funct. 37:525–533. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Wang J, Wang B, Ren H and Chen W: miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun. 509:241–248. 2019. View Article : Google Scholar : PubMed/NCBI

12 

Shi D, Wang H, Ding M, Yang M, Li C, Yang W and Chen L: MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in thyroid cancer. Onco Targets Ther. 12:6605–6616. 2019. View Article : Google Scholar : PubMed/NCBI

13 

Guo F, Hou X and Sun Q: MicroRNA-9-5p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF. Oncol Lett. 16:6815–6821. 2018.PubMed/NCBI

14 

Chen Z, Liu Z, Shen L and Jiang H: Long non-coding RNA SNHG7 promotes the fracture repair through negative modulation of miR-9. Am J Transl Res. 11:974–982. 2019.PubMed/NCBI

15 

Wang Y, Han J, Lv Y and Zhang G: miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4. Onco Targets Ther. 12:4225–4233. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Li C, Zhou Y, Cai Y, Shui C, Liu W, Wang X, Jiang J, Zeng D, Gui C and Sun R: Parthenolide inhibits the proliferation of MDA-T32 thyroid cancer cells in vitro and in mouse tumor xenografts and activates autophagy and apoptosis by downregulation of the mammalian target of rapamycin (mTOR)/PI3K/AKT Signaling Pathway. Med Sci Monit. 25:5054–5061. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI

19 

Chandrashekar DS, Bashel B, Balasubramanya SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Chehrehasa F, Meedeniya AC, Dwyer P, Abrahamsen G and Mackay-Sim A: EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods. 177:122–130. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Mas-Ponte D, Carlevaro-Fita J, Palumbo E, Hermoso Pulido T, Guigo R and Johnson R: LncATLAS database for subcellular localization of long noncoding RNAs. RNA. 23:1080–1087. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife. 4:e050052015. View Article : Google Scholar

24 

Zatroch KK, Knight CG, Reimer JN and Pang DS: Refinement of intraperitoneal injection of sodium pentobarbital for euthanasia in laboratory rats (Rattus Norvegicus). BMC Vet Res. 13:602017. View Article : Google Scholar : PubMed/NCBI

25 

Deng Y, Zhao F, Zhang Z, Sun F and Wang M: Long noncoding RNA SNHG7 promotes the tumor growth and epithelial-to-mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm. 33:365–372. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Shan Y, Ma J, Pan Y, Hu J, Liu B and Jia L: lncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 9:7222018. View Article : Google Scholar : PubMed/NCBI

27 

Li Y, Zhao L, Li N, Miao Y, Zhou H and Jia L: miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1. Oncol Rep. 37:2193–2200. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Li Q, Chang Y, Mu L and Song Y: MicroRNA-9 enhances chemotherapy sensitivity of glioma to TMZ by suppressing TOPO II via the NF-κB signaling pathway. Oncol Lett. 17:4819–4826. 2019.PubMed/NCBI

29 

Amit M, Na'ara S, Francis D, Matanis W, Zolotov S, Eisenhaber B, Eisenhaber F, Weiler Sagie M, Malkin L, Billan S, et al: Post-translational regulation of radioactive iodine therapy response in thyroid cancer. J Natl Cancer Inst. Dec 1–2017.(Epub ahead of print). doi: 10.1093/jnci/djx092. View Article : Google Scholar : PubMed/NCBI

30 

Hu X, Ding D, Zhang J and Cui J: Knockdown of lncRNA HOTAIR sensitizes breast cancer cells to ionizing radiation through activating miR-218. Biosci Rep. 39:BSR201810382019. View Article : Google Scholar : PubMed/NCBI

31 

Wang L, Xu T, Cui X, Han M, Zhou LH, Wei ZX, Xu ZJ and Jiang Y: Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1. Eur Rev Med Pharmacol Sci. 23:6186–6193. 2019.PubMed/NCBI

32 

Sun BZ, Ji DG, Feng ZX and Wang Y: Long noncoding RNA SNHG7 represses the expression of RBM5 to strengthen metastasis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 23:5699–5704. 2019.PubMed/NCBI

33 

Wang YH, Huo BL, Li C, Ma G and Cao W: Knockdown of long noncoding RNA SNHG7 inhibits the proliferation and promotes apoptosis of thyroid cancer cells by downregulating BDNF. Eur Rev Med Pharmacol Sci. 23:4815–4821. 2019.PubMed/NCBI

34 

Chen K, Abuduwufuer A, Zhang H, Luo L, Suotesiyali M and Zou Y: SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 23:6935–6943. 2019.PubMed/NCBI

35 

Wu P, Tang Y, Fang X, Xie C, Zeng J, Wang W and Zhao S: Metformin suppresses hypopharyngeal cancer growth by epigenetically silencing long Non-coding RNA SNHG7 in FaDu Cells. Front Pharmacol. 10:1432019. View Article : Google Scholar : PubMed/NCBI

36 

Fan Y, Shi Y, Lin Z, Huang X, Li J, Huang W, Shen D, Zhuang G and Liu W: miR-9-5p suppresses malignant biological behaviors of human gastric cancer cells by negative regulation of TNFAIP8L3. Dig Dis Sci. 64:2823–2829. 2019. View Article : Google Scholar : PubMed/NCBI

37 

Xie CH, Cao YM, Huang Y, Shi QW, Guo JH, Fan ZW, Li JG, Chen BW and Wu BY: Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression. Tumour Biol. 37:15031–15041. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Wei W, Dong Z, Gao H, Zhang YY, Shao LH, Jin LL, Lv YH, Zhao G, Shen YN and Jin SZ: MicroRNA-9 enhanced radiosensitivity and its mechanism of DNA methylation in non-small cell lung cancer. Gene. 710:178–185. 2019. View Article : Google Scholar : PubMed/NCBI

39 

Javidroozi M, Zucker S and Chen WT: Plasma seprase and DPP4 levels as markers of disease and prognosis in cancer. Dis Markers. 32:309–320. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol. 11:892018. View Article : Google Scholar : PubMed/NCBI

41 

Yi J and Gao ZF: MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4. Int J Biol Macromol. 130:1–9. 2019. View Article : Google Scholar : PubMed/NCBI

42 

Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ, Kim JH, Yin J, Yoo H, Lee SH and Park JB: Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One. 7:e474492012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen W, Yu J, Xie R, Zhou T, Xiong C, Zhang S and Zhong M: Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation. Oncol Rep 45: 3, 2021.
APA
Chen, W., Yu, J., Xie, R., Zhou, T., Xiong, C., Zhang, S., & Zhong, M. (2021). Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation. Oncology Reports, 45, 3. https://doi.org/10.3892/or.2021.7954
MLA
Chen, W., Yu, J., Xie, R., Zhou, T., Xiong, C., Zhang, S., Zhong, M."Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation". Oncology Reports 45.4 (2021): 3.
Chicago
Chen, W., Yu, J., Xie, R., Zhou, T., Xiong, C., Zhang, S., Zhong, M."Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation". Oncology Reports 45, no. 4 (2021): 3. https://doi.org/10.3892/or.2021.7954
Copy and paste a formatted citation
x
Spandidos Publications style
Chen W, Yu J, Xie R, Zhou T, Xiong C, Zhang S and Zhong M: Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation. Oncol Rep 45: 3, 2021.
APA
Chen, W., Yu, J., Xie, R., Zhou, T., Xiong, C., Zhang, S., & Zhong, M. (2021). Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation. Oncology Reports, 45, 3. https://doi.org/10.3892/or.2021.7954
MLA
Chen, W., Yu, J., Xie, R., Zhou, T., Xiong, C., Zhang, S., Zhong, M."Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation". Oncology Reports 45.4 (2021): 3.
Chicago
Chen, W., Yu, J., Xie, R., Zhou, T., Xiong, C., Zhang, S., Zhong, M."Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation". Oncology Reports 45, no. 4 (2021): 3. https://doi.org/10.3892/or.2021.7954
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team